LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Celladon Corp.
Headquarters:
San Diego, CA, United States
Website:
N/A
Year Founded:
2004
Status:
Merged
BioCentury
|
Aug 31, 2018
Financial News
Ascentage hops in Hong Kong IPO queue
Read More
BioCentury
|
Aug 20, 2018
Financial News
Ascentage hops in Hong Kong IPO queue
Read More
BioCentury
|
Oct 23, 2017
Preclinical News
Researchers identify new targets for DMD
Read More
BioCentury
|
Dec 2, 2015
Company News
Management tracks
Read More
BioCentury
|
Nov 20, 2015
Company News
Eiger reverse-merges with Celladon
Read More
BioCentury
|
Oct 5, 2015
Finance
Event planner
Investors' top names, milestones and meetings in 4Q15
Read More
BioCentury
|
Jul 27, 2015
Strategy
Rules of competition
How companies can compete with gene therapies that provide a functional cure
Read More
BioCentury
|
Jul 23, 2015
Tools & Techniques
Gene therapy's coming of age
Why gene therapy is hot after more than 20 years of research
Read More
BioCentury
|
Jul 13, 2015
Finance
Big news
Biotech names and milestones investors like heading into 2H15
Read More
BioCentury
|
Jul 13, 2015
Company News
Celladon cardiovascular news
Read More
Items per page:
10
1 - 10 of 90